Abstract

Objective The paper aimed to explore the mechanism of Forsythin regulating miRNA expression in laryngeal carcinoma cells, and to clarify the molecular biological mechanism of Forsythin regulating miRNA to promote the apoptosis of laryngeal carcinoma cells, providing theoretical and experimental basis for clinical application of Forsythin as an anti-laryngeal cancer treatment drug. Methods: A miR-1469 low-expression laryngeal carcinoma cell line was established. Western blot and flow cytometry were applied to detect the effect of Forsythin on cell apoptosis. Western blot was employed to detect the effects of Forsythin on P53 protein, P53 low expression, and P53 overexpression in laryngeal carcinoma cells, as well as the effects on overexpression of miRNA-1469, and on double low expression of P53 and Mcl1. Real-time PCR method was used to detect the effect of miR-1469 on p53 low expression in laryngeal carcinoma cells. Results: Flow cytometry detection of cell apoptosis showed that, after the cells with low miR-1469 expression were treated with Forsythin, the apoptosis rate was significantly reduced. Western blot detection showed that, compared with the Control group, the expression level of miR-1469 was significantly reduced after Forsythin administration in Hep2 cells with low expression of P53. Compared with the idle Control group, the apoptosis level of laryngeal carcinoma cells in Hep2 cells with low expression of P53 was significantly reduced. In Hep2 cells transfected with P53 overexpression plasmids, apoptosis level of laryngeal carcinoma cells increased. Compared with the idle Control group, the apoptosis level of laryngeal carcinoma cells in the single-transformed P53 shRNA group decreased, while the apoptosis level of the double-transformed miR-1469 mimic+P53 shRNA group increased again. After drug treatment, the apoptosis level of the single-transformed P53 shRNA group decreased, while the apoptosis level of the double-transformed Mcl1 shRNA+P53 shRNA group increased again. Conclusion: Forsythin can promote the apoptosis of laryngeal carcinoma cells by up-regulating the expression of miR-1469 and then down-regulating the expression of Mcl1. The drug can up-regulate the expression of miR-1469 by elevating the expression of P53. miR-1469 can promote the apoptosis of laryngeal carcinoma cells by inhibiting the expression of its downstream target gene Mcl1.

Highlights

  • Laryngeal cancer is a common malignant tumor of the head and neck

  • Studies have found that p53 can up-regulate the expression of miR-29c in colon carcinoma cells, and miR-29c can act on its downstream target gene PHLDB2 to down-regulate its expression, thereby inhibiting the invasion and metastasis of colon carcinoma cells

  • The expression level of PARP splicing protein in laryngeal carcinoma cells with high p53 expression was increased. This indicates that the pro-apoptotic effect of Forsythin on laryngeal carcinoma cells is enhanced, proving that Forsythin can promote the apoptosis of laryngeal carcinoma cells by up-regulating the expression of P53

Read more

Summary

Introduction

Laryngeal cancer is a common malignant tumor of the head and neck. It is the second most common malignant tumor of the respiratory tract. The main causes of laryngeal cancer are smoking, drinking, air pollution, occupational factors, and papilloma virus infection. With the increasing aging of the population, the high smoking rate and air pollution and other factors, the incidence of laryngeal cancer in China is not optimistic (Obid et al, 2019). The surgery, radiotherapy and chemotherapy and targeted therapy technology for laryngeal cancer have made significant progress, the five-year survival rate is still around 60.9%, with no significant improvement over the past (Jaiswal et al, 2019). It is still of great importance to find new therapeutic targets and methods for the treatment of laryngeal cancer

Methods
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call